3 Of 5 Remaining Claims Of Kickbacks Survive In Cancer Drug Lawsuit
PHILADELPHIA — A Pennsylvania federal judge on Nov. 12 said a whistleblower’s claims that Sanofi caused the submission of false claims through its use of advisory boards, speaker programs and educational...To view the full article, register now.
Already a subscriber? Click here to view full article